Atea Pharmaceuticals, Inc. (AVIR) financial statements and ratios from SEC XBRL: revenue $351.37M (TTM), net margin 34.5%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $351.37M |
| Net Margin | 34.5% |
| Price / Book | 2.13 |
| Sector P/E (Healthcare) | 21.7 |
AVIR overview · AVIR earnings · AVIR KPIs · AVIR investor relations · AVIR ownership · AVIR peers · AVIR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.